Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (20)

2024

  1. Factors Associated with SARS-CoV-2 Infection in Fully Vaccinated Nursing Home Residents and Workers

    Viruses, Vol. 16, Núm. 2

  2. Respiratory syncytial virus: A new era

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 134-148

2023

  1. Advantages and disadvantages of maintaining the mandatory use of masks in health centers and nursing homes in Spain. How and when is it justified to maintain it?

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 466-469

  2. Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review

    Journal of Clinical Medicine, Vol. 12, Núm. 21

  3. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)

    Frontiers in Microbiology, Vol. 14

  4. Tuberculosis in Spain: An opinion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 6, pp. 562-583

2022

  1. Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults

    Antibiotics, Vol. 11, Núm. 9

  2. Decalogue for the selection of oral antibiotics for lower respiratory tract infections

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 16-29

  3. Specific high-resolution scheme to improve understanding of the spatio-temporal dispersion of lymphogranuloma venereum epidemic

    Frontiers in Microbiology, Vol. 13

2021

  1. Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection

    Clinical Microbiology and Infection, Vol. 27, Núm. 5, pp. 758-761

2019

  1. Current approach to fosfomycin: From bench to bedside

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 1, pp. 1-3

  2. Monitoring the antimicrobial susceptibility of gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the smart study (Spain, 2016 and 2017)

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 145-155

2018

  1. Antibiotic selection in the treatment of acute invasive infections by pseudomonas aeruginosa: Guidelines by the Spanish society of chemotherapy

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 1, pp. 78-100

  2. Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among gram-negative organisms recovered during the SMART study in Spain (2011-2015)

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 2, pp. 136-145

2017

  1. Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 2, pp. 431-436

2011

  1. Antimicrobial susceptibility of gram-negative organisms from intra abdominal infections and evolution of isolates with extended spectrum β-lactamases in the smart study in spain (2002-2010)

    Revista Espanola de Quimioterapia, Vol. 24, Núm. 4, pp. 223-232

2007

  1. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

2003

  1. Antibiotic resistance and clinical significance of Haemophilus influenzae type f

    Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 6, pp. 961-966

  2. Evolución de la resistencia antibiótica de Pseudomonas aeruginosa, Escherichia coli y Bacteroides fragilis (1997-2001)

    Revista Espanola de Quimioterapia, Vol. 16, Núm. 4, pp. 421-427

1992

  1. Aminoglycoside-modifying enzymes in clinical isolates harboring extended- spectrum β-lactamases

    Antimicrobial Agents and Chemotherapy